Table 1.
Subject characteristics.
| IGRA+ group |
IGRA- Healthy control group |
||
|---|---|---|---|
| Number | 18 | 4 | |
| Age in years: Median (IQR) | 34 (28–38) | 28 (27–29) | |
| Gender | Male | 10 (56%) | 3 (75%) |
| Female | 8 (44%) | 1 (25%) | |
| Confirmed recent drug-susceptible TB exposure | Yes | 15 (83%) | 0 (0%) |
| No | 3 (17%) | 4 (100%) | |
| BCG | Yes | 14 (78%) | 2 (50%) |
| No | 2 (11%) | 2 (50%) | |
| Unknown | 2 (11%) | 0 (0%) | |
| Continent of Birth | Africa | 4 (22%) | 0 (0%) |
| Asia | 4 (22%) | 0 (0%) | |
| Australasia | 0 (0%) | 1 (25%) | |
| Europe | 9 (50%) | 2 (50%) | |
| North America | 0 (0%) | 1 (25%) | |
| South America | 1 (6%) | 0 (0%) | |
| Unknown | 0 (0%) | 0 (0%) | |
| Ethnicity | Asiana | 5 (28%) | 2 (50%) |
| Blackb | 4 (22%) | 0 (0%) | |
| Whitec | 8 (44%) | 2 (50%) | |
| Otherd | 1 (6%) | 0 (0%) | |
Includes Bengali, Hong Kong, Kurdish, Sri Lankan, Turkish.
Includes Black African.
Includes White British, Polish, Romanian, White other.
Includes Latin American, Unknown.